Bepotastine besilate for the treatment of pruritus

Allergic conjunctivitis: The evolution of therapeutic options

(2012) Leonard Bielory   ALLERGY AND ASTHMA PROCEEDINGS

Ophthalmic antihistamines and H1–H4 receptors

(2012) Laurie Wade et al.   Current Opinion in Allergy and Clinical Immunology

Effects of Bepotastine and Fexofenadine on Histamine-Induced Flare, Wheal and Itch

(2012) Hideaki Tanizaki et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Prevalence and Risk Factors of Dry Eye Syndrome in a United States Veterans Affairs Population

(2011) Anat Galor et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Health-related quality of life assessed by the effect of bepotastine besilate in patients with pruritus: Importance of emotions score in atopic dermatitis

(2011) Tamihiro KAWAKAMI et al.   JOURNAL OF DERMATOLOGY

Prolonged Effectiveness of Bepotastine Besilate Ophthalmic Solution for the Treatment of Ocular Symptoms of Allergic Conjunctivitis

(2011) Jon I. Williams et al.   JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS

Multicenter Clinical Evaluation of Bepotastine Besilate Ophthalmic Solutions 1.0% and 1.5% to Treat Allergic Conjunctivitis

(2010) Thomas T. Macejko et al.   AMERICAN JOURNAL OF OPHTHALMOLOGY

Bepotastine besilate ophthalmic solution for the relief of nonocular symptoms provoked by conjunctival allergen challenge

(2010) Gail L. Torkildsen et al.   ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY

The Economic Burden of Dry Eye Disease in the United States: A Decision Tree Analysis

(2010) Junhua Yu et al.   CORNEA

Non-clinical pharmacology, pharmacokinetics, and safety findings for the antihistamine bepotastine besilate

(2010) Jon I. Williams et al.   CURRENT MEDICAL RESEARCH AND OPINION

Oral Bepotastine

(2010) Katherine A. Lyseng-Williamson   DRUGS

Bepotastine besilate, a highly selective histamine H1 receptor antagonist, suppresses vascular hyperpermeability and eosinophil recruitment in in vitro and in vivo experimental allergic conjunctivitis models

(2010) Tetsuo Kida et al.   EXPERIMENTAL EYE RESEARCH

The epidemiology of ocular and nasal allergy in the United States, 1988-1994

(2010) Kavita Singh et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

New drugs: Asenapine, iloperidone, and bepotastine besilate

(2010) Daniel A. Hussar et al.   JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION

Time to onset and duration of action of the antihistamine bepotastine besilate ophthalmic solutions 1.0% and 1.5% in allergic conjunctivitis: A phase III, single-center, prospective, randomized, double-masked, placebo-controlled, conjunctival allergen challenge assessment in adults and children

(2009) Mark B. Abelson et al.   CLINICAL THERAPEUTICS

Estimate of the direct and indirect annual cost of bacterial conjunctivitis in the United States

(2009) Andrew F Smith et al.   BMC Ophthalmology

Brain histamine H1receptor occupancy of orally administered antihistamines, bepotastine and diphenhydramine, measured by PET with11C-doxepin

(2008) Manabu Tashiro et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Allergic Conjunctivitis

(2008) Leonard Bielory et al.   IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA

Intact Cell Binding for In Vitro Prediction of Sedative and Non-sedative Histamine H1–Receptor Antagonists Based on Receptor Internalization

(2008) Shigeru Hishinuma et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES